Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Histone Demethylase

Histone demethylase proteins have a variety of domains that serve different functions. These functions include binding to the histone (or sometimes the DNA on the nucleosome), recognizing the correct methylated amino acid substrate and catalyzing the reaction, and binding cofactors. Cofactors include: alpha-keto glutarate (JmjC-domain containing demethylases), CoREST (LSD), FAD, Fe (II) or NOG (N-oxalylglycine).

KDM4-IN-4
T603542230475-63-3In house
KDM4-IN-4 (compound 47) is a potent inhibitor of histone lysine demethylase 4 (KDM4), with a binding constant of approximately 80 μM for the KDM4A-Tudor domain. It inhibits H3K4Me3 binding to the Tudor domain in cellular contexts with an EC50 value of 105 μM, holding potential for anticancer research applications [1].
  • $293
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Zavondemstat
T701211851412-93-5In house
Zavondemstat (QC8222 free base) is a histone lysine demethylase 4 (KDM4) inhibitor with anticancer and antitumor activity for the study of triple-negative and breast cancers.
  • $152
In Stock
Size
QTY
TargetMol | Inhibitor Hot
T-448
T130571597426-53-3In house
T-448 is a specific, orally active, and irreversible inhibitor of lysine-specific demethylase 1 (LSD1, an H3K4 demethylase) with an IC50 of 22 nM.
  • $455
In Stock
Size
QTY
GSK-J4 Hydrochloride
T43831797983-09-5
GSK-J4 Hydrochloride (GSK J4 HCl) is a cell permeable, potent and selective histone demethylase(JMJD3 )inhibitor. is an ethyl ester derivative of the GSK-J1 with an IC50 value greater than 50 μM in vitro.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
GSK-J4
T31001373423-53-0In house
GSK-J4 (GSK J4 HCl) is a cell permeable prodrug of GSK-J1, a dual inhibitor of the H3K27me3 me2 demethylases JMJD3 KDM6B and UTX KDM6A (IC50=8.6 6.6 μM). GSK-J4 induces endoplasmic reticulum stress-related apoptosis.
  • $51
In Stock
Size
QTY
TargetMol | Citations Cited
CPI-455
T35521628208-23-0
CPI-455 is a specific KDM5 inhibitor.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
KDM2A/7A-IN-1
T117482169272-46-0In house
KDM2A 7A-IN-1 is a cell-permeable and selective inhibitor of histone lysine demethylase KDM2A 7A, with potential antitumor activity for studying duodenal adenomas and ossifying fibromucoid tumors.
  • $272 TargetMol
In Stock
Size
QTY
GSK467
T54841628332-52-4
GSK467 is a potent and selective inhibitor of KDM5 (JARID1)(Ki : 10 nM).
  • $74
In Stock
Size
QTY
GSK-LSD1 dihydrochloride
T23152102933-95-7
GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
  • $34
In Stock
Size
QTY
Corin
T108641808113-09-8In house
Corin is an irreversible inhibitor of HDAC1(IC50 = 147 nM) and LSD1(Ki = 110 nM).
  • $179
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Bomedemstat ditosylate
T700081990504-72-7In house
Bomedemstat ditosylate (IMG-7289 ditosylate) is an orally active lysine-specific demethylase 1 (LSD1) inhibitor with antitumor activity that potentiates the response to PD-1 inhibition in a homozygous model of SCLC, inhibits cancer cell proliferation, and induces apoptosis. Bomedemstat ditosylate can be used to study myeloproliferative neoplasms and myelofibrosis.
  • $117
In Stock
Size
QTY
AS8351
T4100796-42-9
AS8351 (NSC51355) is a histone demethylase inhibitor. It has been used in combination with CHIR99021, A 83-01, BIX01294, SC-1, Y-27632, OAC2, SU 16f, and JNJ-10198409 to induce reprogramming of human fetal lung fibroblasts into functional cardiomyocytes.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
3-pyridine toxoflavin
T6773832502-20-8
3-pyridine toxoflavin is a potent KDM4C inhibitor, IC50=19nM.
  • $195
In Stock
Size
QTY
TargetMol | Inhibitor Sale
OG-L002
T60731357302-64-7
OG-L002 is an effective and selective LSD1 inhibitor (IC50: 20 nM), showing 69- and 36-fold selectivity over MAO-A and MAO-B, respectively.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KDM1A-IN-29
T888341423715-30-3
KDM1A-IN-29 is a histone demethylase inhibitor.
  • $195
In Stock
Size
QTY
LSD1-IN-20
T631401239589-91-3In house
Lsd1-in-20 is a potent dual inhibitor of LSD1/G9a with Ki values of 0.44 and 0.68 μM, respectively. LSD1-IN-20 showed antiproliferative activity against THP-1 leukemia cells and MDA-MB-231 breast cancer cells in vitro, with IC50 of 0.51 and 1.60 μM, respectively, at 72 h.
  • $397
In Stock
Size
QTY
Pulrodemstat benzenesulfonate
T118822097523-60-7
Pulrodemstat benzenesulfonate (CC-90011 benzenesulfonate) is a potent and orally active inhibitor of lysine specific demethylase-1 (LSD1) with anticancer activity.
  • $55
In Stock
Size
QTY
IOX1
T65455852-78-8
IOX1 is the most effective broad-spectrum 2OG oxygenases(including the JmjC demethylases) inhibitor. The IC50 of IOX1 for KDM4A, KDM3A, is 0.6 and 0.1 uM, respectively.
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
Seclidemstat
T45271423715-37-0
Seclidemstat (SP-2577) is an effective LSD1 inhibitor, with a mean IC50 of 127 nM.
  • $41
In Stock
Size
QTY
NCGC00244536
TQ00502003260-55-5
NCGC00244536 (KDM4B Inhibitor B3) is a potent KDM4B inhibitor (IC50: 10 nM).
  • $97
In Stock
Size
QTY
TargetMol | Inhibitor Sale
DDP-38003 dihydrochloride
T10983L1831167-98-6In house
DDP-38003 dihydrochloride is an orally available histone lysine-specific demethylase 1A (KDM1A/LSD1) inhibitor (IC50: 84 nM).
  • $73
In Stock
Size
QTY
GSK2879552 2HCl (1401966-69-5(free base))
T4418
GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.
  • $54
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
PFI-90
T924353995-62-3
PFI-90, a selective histone demethylase (KDM3B) inhibitor, targets PAX3-FOXO1 action and demonstrates potential antitumor activity. It induces apoptosis and myogenic differentiation, leading to increased cell death.
  • $34
In Stock
Size
QTY
KDM2B-IN-2
T393891965248-01-4
KDM2B-IN-2 is a potent histone demethylase (kdm2b) inhibitor.
  • $60
In Stock
Size
QTY
GSK-LSD1
T822541431368-48-7
GSK-LSD1 is a selective LSD1 inhibitor with potential anticancer activity that attenuates the expression of CTGF CCN2, MMP13, LOXL4, and waveform proteins in cancer cells.GSK-LSD1 regulates the cell cycle, induces apoptosis, and can be used to study breast cancer.
  • $30
In Stock
Size
QTY
Tranylcypromine (2-PCPA) hydrochloride
T10251986-47-6
Tranylcypromine (2-PCPA) hydrochloride (SKF-385 HCl), a Monoamine Oxidase inhibitor, is effective in the treatment of major depression, dysthymic disorder, and atypical depression.
  • $39
In Stock
Size
QTY
PBIT
T164352514-30-9
PBIT inhibits JARID1B histone demethylase (IC50 of about 3 μM). PBIT also inhibits JARID1A and JARID1C (IC50s of 6 μM and 4.9 μM, respectively). PBIT is a specific inhibitor of the Jumonji AT-rich Interactive Domain 1 (JARID1) enzymes .
  • $34
In Stock
Size
QTY
KDM5-C70
T156481596348-32-1
KDM5-C70 is an ethyl ester derivative of KDM5-C49 and functions as an effective, cell-permeable, pan-KDM5 histone demethylase inhibitor. It exhibits an antiproliferative effect in myeloma cells and induces a genome-wide elevation of H3K4me3 levels.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
ORY1001
T69221431326-61-2
ORY1001 (ORY 1001) is an orally active and selective lysine-specific demethylase LSD1 KDM1A inhibitor, with high selectivity against related FAD dependent aminoxidases with IC50 of <20 nM.
  • $54
In Stock
Size
QTY
TargetMol | Citations Cited
KDM5A-IN-1
T156501905481-36-8
KDM5A-IN-1 is an orally available, potent and selective inhibitor of the pan-histidine lysine demethylase 5 KDM5, inhibiting KDM5A, KDM5B, and KDM5C with IC50 values of 45 nM, 56 nM, and 55 nM, respectively.KDM5A-IN-1 inhibits PC9 H3K4Me3, and may be useful in cancer research.
  • $149
In Stock
Size
QTY
Ryuvidine
T23284265312-55-8
Ryuvidine is a dual inhibitor of KDM5A and SETD8, an inducer of the DNA damage response with potential anticancer activity, inhibition of H4K20 methylation, and inhibition of CDK4, and can be used to study breast cancer and erythroplasia.
  • $61
In Stock
Size
QTY
Iadademstat dihydrochloride
T58251431303-72-8
Iadademstat dihydrochloride (ORY-1001(trans)) , a Potent and Selective Covalent KDM1A/LSD1 Inhibitor, for the Treatment of Acute Leukemia.
  • $38
In Stock
Size
QTY
Tranylcypromine hemisulfate
T794213492-01-8
Tranylcypromine hemisulfate (Tranylcypromine Sulfate) is an inhibitor of monoamine oxidase (MAO) and lysine-specific demethylase 1 (LSD1) with a rapid onset of activity.
  • $48
In Stock
Size
QTY
TargetMol | Citations Cited
SP2509
T23041423715-09-6
SP2509 is a specific histone demethylase LSD1 inhibitor(IC50 =13 nM).
  • $52
In Stock
Size
QTY
GSK-J1
T68471373422-53-7
GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and 53 nM in cell-free assays for JMJD3 (KDM6B) and UTX (KDM6A), respectively, >10-fold selectivity over other tested demethylases.
  • $40
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ML324
T65931222800-79-4
ML324(IC50=920 nM) is a specific inhibitor of jumonji histone demethylase (JMJD2).
  • $47
In Stock
Size
QTY
TargetMol | Inhibitor Sale
HDAC3-IN-T247
T241311451042-18-4
HDAC3-IN-T247 (HDAC3 inhibitor T247) is a selective and potent histone deacetylase 3 (HDAC3) inhibitor with anticancer and antiviral activities.HDAC3-IN-T247 induces NF-κB acetylation in human colon cancer HCT116 cells in a dose-dependent manner.HDAC3-IN-T247 inhibits cancer cell proliferation. HDAC3-IN-T247 inhibits cancer cell proliferation.
  • $84
In Stock
Size
QTY
KDM4C-IN-1
T6065452348-60-4
KDM4C-IN-1 is a selective and potent KDM4C inhibitor (IC50: 8 nM) with potential anticancer activity.KDM4C-IN-1 inhibits the growth of HepG2 and A549 cells, and can be used for the study of leukaemia.
  • $99
In Stock
Size
QTY
GSK J5
T228211394854-51-3
GSK J5 is an inhibitor of schistosomes and helminths and is often used as a trematode insecticide.GSK J5 promotes schistosome mortality in a dose- and time-dependent manner.GSK J5 increases the mortality rate of schistosomes and decreases the viability of adult worms.GSK J5 is an inhibitor of schistosomes and helminths and is often used as a trematode insecticide.
  • $39
In Stock
Size
QTY
JIB-04
T1868199596-05-9
JIB-04 (NSC 693627) is a pan-selective Jumonji histone demethylase inhibitor.
  • $30
In Stock
Size
QTY
LSD1-IN-27
T776352904571-94-2
LSD1-IN-27 is a potent LSD1 inhibitor with an IC50 value of 13 nM.LSD1-IN-27 inhibited the stemness and migration of gastric cancer cells.LSD1-IN-27 inhibited the expression of PD-L1 in BGC-823 and MFC cells.LSD1-IN-27 potentiated the T-cell immune response against gastric cancer.
  • $158
In Stock
Size
QTY
Procaine
T002959-46-1
Procaine (Vitamin H3) is a local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block.
  • $30
In Stock
Size
QTY
Procaine hydrochloride
T080251-05-8
Procaine hydrochloride (Novocaine HCl) is the hydrochloride salt form of procaine, a benzoic acid derivative with local anesthetic and antiarrhythmic properties. Procaine binds to and inhibits voltage-gated sodiumchannels, thereby inhibiting the ionic flux required for the initiation and conduction of impulses. In addition, this agent increases electrical excitation threshold, reduces rate of rise of action potential and slows nerve impulse propagation thereby causing loss of sensation.
  • $31
In Stock
Size
QTY
RN-1 dihydrochloride
T216521781835-13-9
RN-1 dihydrochloride is an effective and selective irreversible inhibitor of lysine-specific demethylase 1 (LSD1, IC50 = 70 nM).
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Sale
KDM5-C49 HCl
T27723L
KDM5-C49 HCl (KDOAM-20 hydrochloride) is a potent and selective inhibitor of KDM5 demethylase. KDM5-C49 HCL(1596348-16-1 Free base) is a candidate compound for the treatment of cancer.
  • $195
In Stock
Size
QTY
KDM4D-IN-1
T42142098902-68-0
KDM4D-IN-1 is a KDM4D inhibitor (IC50: 0.41±0.03 μM).
  • $70
In Stock
Size
QTY
Daminozide
T37191596-84-5
Daminozide (Succinic Acid) is a plant growth regulator, selectively inhibits the KDM2 7 JmjC subfamily.
  • $42
In Stock
Size
QTY
L-2-Hydroxyglutaric acid disodium
T1374863512-50-5
L-2-Hydroxyglutaric acid disodium ((S)-2-Hydroxyglutaric acid disodium) is an epigenetic modifier and putative oncometabolite in renal cancer. L-2-Hydroxyglutaric acid inhibits mitochondrial creatine kinase (Mi-CK) activity(Km and Ki of 2.52 mM and 11.13 mM, respectively).
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Sale